Differentiation- and maturation-dependent content, localization, and secretion of cystatin C in human dendritic cells.
Antigen-presenting cells (APC) play a pivotal role in the initiation of the T cell-mediated and antigen-specific immune response. The suggested role of endogenous inhibitor cystatin C (CyC) is to modulate cysteine proteases (cathepsins) present in human APC. To test this hypothesis, dendritic cells (DC) were generated in vitro from isolated monocytes, and changes in content, localization, and secretion of CyC and cathepsins S, L, and H (CatS, -L, and -H, repsectively) were followed in response to interleukin-4, enabling monocyte differentiation, and to tumor necrosis factor alpha (TNF-alpha), enabling DC maturation. A large increase in intracellular CyC accompanied the differentiation of monocytes to immature DC, also shown by strong immunolabeling of Golgi in immature DC. On DC maturation, intracellular CyC levels decreased, and CyC was mostly absent from the Golgi. On prolonged incubation of mature DC with TNF-alpha, CyC was found located in the proximity of the plasma membrane, indicating that the transport of CyC from Golgi was not blocked as the result of the arrested exocytosis in mature DC. The secretion of CyC ceased, consistent with the peak of the surface expression of phenotypic markers (CD40, CD54, CD80, CD83, CD86, and major histocompatibility complex class II), characteristic for the mature DC stage, whereas the secretion of cathepsins did not correlate with the maturation stage. The difference in localization of CyC and of CatS, -L, and -H in immature and mature DC shows that the regulatory potential of CyC toward CatS, -L, and -H inside DC is limited. However, these interactions may occur extracellularly in lymph, as suggested by the large excess of CyC over secreted CatS, -L, and -H, and they may facilitate DC migration to lymph nodes.
Zavasnik-Bergant
Tina
T
Department of Biochemistry and Molecular Biology, JoZef Stefan Institute, Ljubljana, Slovenia, EU. tina.zavasnik@ijs.si
Repnik
Urska
U
Schweiger
Ana
A
Romih
Rok
R
Jeras
Matjaz
M
Turk
Vito
V
Kos
Janko
J
D017951:Antigen Presentation / Q000187:drug effects / Q000276:immunology; D000954:Antigens, Surface / Q000187:drug effects / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D002403:Cathepsins / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D002454:Cell Differentiation / Q000187:drug effects / Q000276:immunology*; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects / Q000276:immunology; D055316:Cystatin C; D015891:Cystatins / Q000276:immunology / Q000378:metabolism*; D003713:Dendritic Cells / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D005089:Exocytosis / Q000187:drug effects / Q000276:immunology; D006056:Golgi Apparatus / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000276:immunology; D007155:Immunologic Factors / Q000276:immunology / Q000378:metabolism*; D015847:Interleukin-4 / Q000494:pharmacology; D008198:Lymph Nodes / Q000166:cytology / Q000276:immunology; D009000:Monocytes / Q000187:drug effects / Q000276:immunology; D021381:Protein Transport / Q000187:drug effects / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D015854:Up-Regulation / Q000187:drug effects / Q000276:immunology
D000954:Antigens, Surface; D015415:Biomarkers; C525030:CST3 protein, human; D055316:Cystatin C; D015891:Cystatins; D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha; D015847:Interleukin-4; D002403:Cathepsins